News Related to Metabolic Dysfunction-Associated Liver Cancer

Related coverage linked through entity extraction aliases.

AI-Driven Biomarker Identifies High-Risk Liver Cancer Patients Before Tumor Formation

Feb 18, 2026

Researchers at RIKEN Center for Integrative Medical Sciences in Japan have developed a machine-learning algorithm that predicts hepatocellular carcinoma risk by analyzing the MYCN protein and tumor-promoting microenvironments in liver tissue before malignancy manifests.

AI and Machine Learning Advance Cancer Biomarker Discovery and Treatment Strategies

Feb 18, 2026

Researchers develop machine-learned biomarker predicting liver cancer risk with 93% accuracy, while AI-driven drug repurposing offers faster, cost-effective alternatives to address cancer survivorship gaps.